HIV-AIDS Hematology : NIDDK

HIV-AIDS Hematology

Specific areas include:

  • Studies of the effects of HIV infection and anti-viral HIV therapies on hematopoiesis and the hematopoietic microenvironment.
  • Development of novel gene therapy approaches for treating HIV infection based on auto-transplantation of genetically modified hematopoietic stem cells.
  • Impact of HIV infection and of anti-viral HIV therapies on immunosuppressive management for hematopoietic stem cell and organ transplantation.

For more information, contact Dr. Daniel Wright, Hematology Program Director..

Resources for Researchers

Clinical Research


  • Centers of Excellence in Molecular Hematology - Overview & Map

Related Study Sections


See Also

Funding Opportunities

Funding for Special Communities


Related Reports

Committees and Advisory Groups

Related Organizations

Some documents on this page are in Adobe Acrobat PDF format. You must have Adobe Acrobat Reader installed on your computer to view them. To download Adobe Acrobat Reader, go to the Adobe Acrobat Reader download site.


Adobe Acrobat Reader download site:

Page last updated: January 23, 2009

General inquiries may be addressed to: Office of Communications & Public Liaison
Building 31. Rm 9A06
31 Center Drive, MSC 2560
Bethesda, MD 20892-2560
For information about NIDDK programs: 301.496.3583

The National Institutes of Health   Department of Health and Human Services is the U.S. government's official web portal to all federal, state, and local government web resources and services.  HONcode Seal - Link to the Health on the Net Foundation